Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 361 AL 375

Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases

Far BF, Safaei M, Pourmolaei A, Adibamini S, Shirdel S, Shirdel S, Emadi R, Kaushik AK.

ACS Appl Bio Mater. 2024 Jun 17;7(6):3535-3555. doi: 10.1021/acsabm.4c00112. Epub 2024 May 20.

Photobiomodulation in experimental models of Alzheimer's disease: state-of-the-art and translational perspectives

Huang Z, Hamblin MR, Zhang Q.

Alzheimers Res Ther. 2024 May 21;16(1):114. doi: 10.1186/s13195-024-01484-x.

Strategies for measuring concentrations and forms of amyloid-β peptides

Shen H, Liu K, Kong F, Ren M, Wang X, Wang S.

Biosens Bioelectron. 2024 Sep 1;259:116405. doi: 10.1016/j.bios.2024.116405. Epub 2024 May 18.

Pericytes in Alzheimer's disease: Key players and therapeutic targets

Zhang Y, Mu BR, Ran Z, Zhu T, Huang X, Yang X, Wang DM, Ma QH, Lu MH.

Exp Neurol. 2024 Sep;379:114825. doi: 10.1016/j.expneurol.2024.114825. Epub 2024 May 21.

Vitamin D, Alzheimer's disease and related dementia

Shea MK, Xuan AY, Booth SL.

Adv Food Nutr Res. 2024;109:185-219. doi: 10.1016/bs.afnr.2023.12.003. Epub 2024 Jan 5.

Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy

Liu Y, Xia X, Zheng M, Shi B.

Adv Mater. 2024 Jul;36(29):e2314354. doi: 10.1002/adma.202314354. Epub 2024 May 22.

Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease

Gedam M, Zheng H.

Eur J Immunol. 2024 Aug;54(8):e2350815. doi: 10.1002/eji.202350815. Epub 2024 May 22.

Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?

Duda-Madej A, Stecko J, Szymańska N, Miętkiewicz A, Szandruk-Bender M.

Front Cell Infect Microbiol. 2024 May 8;14:1393809. doi: 10.3389/fcimb.2024.1393809. eCollection 2024.

Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid

Garcia Ratés S, García-Ayllón MS, Falgàs N, Brangman SA, Esiri MM, Coen CW, Greenfield SA.

Alzheimers Dement. 2024 Jul;20(7):5027-5034. doi: 10.1002/alz.13869. Epub 2024 May 23.

Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress

Bhadane P, Roul K, Belemkar S, Kumar D.

Brain Res. 2024 Oct 1;1840:149018. doi: 10.1016/j.brainres.2024.149018. Epub 2024 May 21.

A potential new treatment for Alzheimer's disease … and other research

Nolan T.

BMJ. 2024 May 23;385:q1125. doi: 10.1136/bmj.q1125.

The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical review

Buck A, Rezaei K, Quazi A, Goldmeier G, Silverglate B, Grossberg GT.

Expert Rev Neurother. 2024 Jun;24(6):607-614. doi: 10.1080/14737175.2024.2355981. Epub 2024 May 24.

A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories

Duchesne S, Rousseau LS, Belzile-Marsolais F, Welch LA, Cournoyer B, Arseneau M, Lapierre V, Poulin SM, Potvin O, Hudon C.

J Alzheimers Dis. 2024;99(3):843-856. doi: 10.3233/JAD-230772.

Ferroptosis: A new strategy for targeting Alzheimer's disease

Qiang RR, Xiang Y, Zhang L, Bai XY, Zhang D, Li YJ, Yang YL, Liu XL.

Neurochem Int. 2024 Sep;178:105773. doi: 10.1016/j.neuint.2024.105773. Epub 2024 May 23.

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

Rebassa JB, Capó T, Lillo J, Raïch I, Reyes-Resina I, Navarro G.

Int J Mol Sci. 2024 May 15;25(10):5378. doi: 10.3390/ijms25105378.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias